Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

F Chambers

Showing results (481-490 of 520) with videos related to

Pageof 52
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2018
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream InfectionSarah B Doernberg, Thuy Tien Tram Tran, Steven Y C Tong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2023
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial PneumoniaJessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2024
<i>In vitro</i> activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant <i>Acinetobacter baumannii</i> collected in U.S. hospitalsAlina Iovleva, Christi L McElheny, Erin L Fowler, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 3, 2024
Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infectionsSelvi C Ersoy, Sabrina L Madrigal, Liang Chen, et al.
The American Journal of Pathology|July 4, 2006
Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancerAlison L Allan, Rosamma George, Sharon A Vantyghem, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2021
Antibacterial Resistance Leadership Group 2.0: Back to BusinessHenry F Chambers, Scott R Evans, Robin Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical TrialsJessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
The Journal of Infectious Diseases|November 30, 2013
Global gene expression of methicillin-resistant Staphylococcus aureus USA300 during human and mouse infectionShailesh V Date, Zora Modrusan, Michael Lawrence, et al.
Mbio|April 9, 2015
USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locusSusan Boyle-Vavra, Xue Li, Md Tauqeer Alam, et al.
Cell Reports|September 2, 2014
Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasisHon S Leong, Amy E Robertson, Konstantin Stoletov, et al.
Pageof 52

Showing results (481-490 of 520) with videos related to

Sort By:
Pageof 52
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|October 16, 2018
Good Studies Evaluate the Disease While Great Studies Evaluate the Patient: Development and Application of a Desirability of Outcome Ranking Endpoint for Staphylococcus aureus Bloodstream InfectionSarah B Doernberg, Thuy Tien Tram Tran, Steven Y C Tong, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 23, 2023
Moving Beyond Mortality: Development and Application of a Desirability of Outcome Ranking (DOOR) Endpoint for Hospital-Acquired Bacterial Pneumonia and Ventilator-Associated Bacterial PneumoniaJessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
Antimicrobial Agents and Chemotherapy|January 30, 2024
<i>In vitro</i> activity of sulbactam-durlobactam against colistin-resistant and/or cefiderocol-non-susceptible, carbapenem-resistant <i>Acinetobacter baumannii</i> collected in U.S. hospitalsAlina Iovleva, Christi L McElheny, Erin L Fowler, et al.
Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases|December 3, 2024
Phenotypic and genotypic correlates of the sodium bicarbonate-responsive phenotype among methicillin-resistant Staphylococcus aureus isolates from skin and soft-tissue infectionsSelvi C Ersoy, Sabrina L Madrigal, Liang Chen, et al.
The American Journal of Pathology|July 4, 2006
Role of the integrin-binding protein osteopontin in lymphatic metastasis of breast cancerAlison L Allan, Rosamma George, Sharon A Vantyghem, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|February 15, 2021
Antibacterial Resistance Leadership Group 2.0: Back to BusinessHenry F Chambers, Scott R Evans, Robin Patel, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 28, 2022
Improving Traditional Registrational Trial End Points: Development and Application of a Desirability of Outcome Ranking End Point for Complicated Urinary Tract Infection Clinical TrialsJessica Howard-Anderson, Toshimitsu Hamasaki, Weixiao Dai, et al.
The Journal of Infectious Diseases|November 30, 2013
Global gene expression of methicillin-resistant Staphylococcus aureus USA300 during human and mouse infectionShailesh V Date, Zora Modrusan, Michael Lawrence, et al.
Mbio|April 9, 2015
USA300 and USA500 clonal lineages of Staphylococcus aureus do not produce a capsular polysaccharide due to conserved mutations in the cap5 locusSusan Boyle-Vavra, Xue Li, Md Tauqeer Alam, et al.
Cell Reports|September 2, 2014
Invadopodia are required for cancer cell extravasation and are a therapeutic target for metastasisHon S Leong, Amy E Robertson, Konstantin Stoletov, et al.
Pageof 52